Springer Science+Business Media has reached an agreement with Wolters Kluwer to acquire the Pharma Marketing and Publishing Services division (MPS).
MPS’s Adis unit publishes a portfolio of 24 highly-regarded scientific journals and newsletters specializing in pharmacology and pharmacotherapy. Further MPS services include drug development and drug safety databases, commercial market analysis, strategic medical and marketing communications programs, prescriber and patient education materials and pharmaceutical sales force training, among others.
The company has approximately 450 employees, and its main offices are in Auckland (New Zealand), Chester (United Kingdom), Yardley, PA (USA) and Milan (Italy).
Derk Haank, CEO of Springer Science+Business Media said: “This acquisition will significantly strengthen our position in international corporate and healthcare markets, and will also allow us to expand Springer’s STM operations, not only in the Americas and Asia-Pacific regions, but also in parts of Europe where we do not yet have offices. MPS’s high-quality content and services for corporate customers and academics form a perfect complement to our existing portfolio.”
Peter Coebergh, Springer’s President Corporate and Healthcare Markets, said: “This acquisition presents an opportunity for Springer and MPS colleagues to jointly come up with creative and useful new ideas for our customers. Combining the strengths of the MPS and Springer Healthcare portfolios will only be the first step to reach this goal.”
Springer Science+Business Media (www.springer.com) is a leading global scientific publisher, delivering quality content through innovative information products and services. The company is also a trusted provider of local-language professional publications in Europe, especially in Germany and the Netherlands. In the science, technology and medicine (STM) sector, the group publishes around 2,000 journals and more than 7,000 new books a year, as well as the largest STM eBook Collection worldwide. Springer has operations in about 20 countries in Europe, the USA, and Asia, and more than 5,500 employees. In 2010, it generated annual sales of around EUR 866 million.